Crosstalk between behavior and immune system during the prodromal stages of alzheimer's disease

Current Pharmaceutical Design

Volumn 20, Issue 29, 2014, Pages 4723-4732

  Giménez Llort, Lydia ^a,b   Torres Lista, Virginia ^a,b   De La Fuente, Mónica ^c  

^a Medical Psychology Unit   (Spain)

^b INSTITUT DE NEUROCIÈNCIES   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Age; Alzheimer's disease; Behavior; Neuroimmunoendocrine communication; Peripheral immune system

Indexed keywords

3XTG MOUSE; AGE; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; BEHAVIOR CHANGE; BIOLOGICAL FUNCTIONS; COGNITION; COGNITIVE RESERVE; DISEASE COURSE; ENVIRONMENTAL ENRICHMENT; EXERCISE; EXPLORATORY BEHAVIOR; FUNCTIONAL STATUS; GLIA CELL; HEALTH STATUS; IMMUNE SYSTEM; IMMUNOMODULATION; LIFESTYLE MODIFICATION; MORBIDITY; NERVE CELL; NERVE CELL NETWORK; NERVOUS SYSTEM FUNCTION; NERVOUS SYSTEM PARAMETERS; NEUROENDOCRINE SYSTEM; NEUROFIBRILLARY TANGLE; NONHUMAN; NUTRITIONAL SUPPORT; OXIDATION REDUCTION STATE; PERIPHERAL NERVOUS SYSTEM; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PRODROMAL SYMPTOM; REGULATORY MECHANISM; SPLEEN; THYMUS; ANIMAL; HUMAN; MOUSE; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; BEHAVIOR; HUMANS; IMMUNE SYSTEM; MICE; MICE, TRANSGENIC; PRODROMAL SYMPTOMS;

EID: 84902674519     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140130205500     Document Type: Article

References (71)

1. Besedovsky HO, Rey AD. Physiology of psychoneuroimmunology. Brain Behav Immun 2007; 21: 34-44.
2. O'Connor JC, McCusker RH, Strle K, Johnson RW, Dantzer R, Kelley KW. Regulation of IGF-I function by proinflammatory cy-tokines: at the interface of immunology and endocrinology. Cell Immunol 2008; 2 52: 91-110.
3. De La Fuente M. Role of neuroimmunomodulation in aging. Neuro-immunomodulation 2008; 15: 213-223.
4. De La Fuente M, Miquel J. An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging. Curr Pharm Des 2009; 15: 3003-3026.
5. Del Rey A. Neuroimmunomodulation in health and disease. II, Translational science/issue editors. Proceedings of the 8th Congress of the International Society for NeuroImmunoModulation (ISNIM); 2011 Oct 20-22; Dresden, Germanny. Annals of the New York Academy of Sciences 2012, ISSN 0077-8923; v. 1262.
6. Qiu Y, Peng Y, Wang J. Immunoregulatory role of neurotransmitters. Adv Neuroimmunol 1996; 6: 223-231.
7. th Congress of the International Society for NeuroImmunoModula-tion (ISNIM); 2011 Oct 20-22; Dresden, Germanny. Neuroimmu-nomodulation 2011; 18: 361-415.
8. th Congress of the International Society for NeuroImmunoModulation (ISNIM); 2011; Dresden, Germanny. Neuroimmunomodulation 2011; 18: 361-415.
9. Jones KA, Thomsen C. The role of the innate immune system in psychiatric disorders. Mol Cell Neurosci 2013; 53: 52-62.
10. Baeza I, Alvarado C, Alvarez P, et al. Improvement of leucocyte functions in ovariectomised aged rats after treatment with growth hormone, melatonin, oestrogens or phyto-oestrogens. J Reprod Immunol 2009; 80: 70-79.
11. th Congress of the International Society for NeuroIm-munoModulation (ISNIM); 2011 Oct 20-22; Dresden, Germanny. Neuroimmunomodulation 2011; 18: 361-415.
12. th Congress of the International Society for NeuroImmuno-Modulation (ISNIM); 2011 Oct 20-22; Dresden, Germanny. Neuro-immunomodulation 2011; 18: 361-415.
13. th Congress of the International Society for NeuroImmunoModulation (ISNIM); 2011 Oct 20-22; Dresden, Germanny. Neuroimmunomodulation 2011; 18: 361-415.
14. th Congress of the International Society for NeuroImmunoModulation (ISNIM); 2011 Oct 20-22; Dresden, Germanny. Neuroimmunomodulation 2011; 18: 361-415.
15. th Congress of the International Society for NeuroImmuno-Modulation (ISNIM); 2011 Oct 20-22; Dresden, Germanny. Neuro-immunomodulation 2011; 18: 361-415.
16. th Congress of the International Society for NeuroImmunoModulation (ISNIM); 2011 Oct 20-22; Dresden, Germanny. Neuroimmunomodulation 2011; 18: 361-415.
17. th Congress of the International Society for NeuroImmunoModulation (ISNIM); 2011 Oct 20-22; Dresden, Germanny. Neuroimmunomodulation 2011; 18: 361-415.
18. th Congress of the International Society for Neuro-ImmunoModulation (ISNIM); 2011 Oct 20-22; Dresden, Ger-manny. Neuroimmunomodulation 2011; 18: 361-415.
19. th Congress of the International Society for Neuro-ImmunoModulation (ISNIM); 2011 Oct 20-22; Dresden, Ger-manny. Neuroimmunomodulation 2011; 18: 361-415.
20. Maccioni RB, Rojo LE, Fernandez JA, Kuljis RO. The role of neuroimmunomodulation in Alzheimer's disease. Ann N Y Acad Sci 2009; 1153: 240-246.
21. Giménez-Llort L, Maté I, Manassra R, Vida C, De La Fuente M. Peripheral immune system and neuroimmune communication impairment in a mouse model of Alzheimer's disease. Ann. N Y Acad Sci 2012; 1262: 74-84.
22. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007; 3: 186-191.
23. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature 2004; 430: 631-639.
24. Reichman WE, Rose NS. History and experience: the direction of Alzheimer's disease. Menopause 2012; 19: 724-734.
25. Molinuevo JL, Sanchez-Valle R, Llado A, Fortea J, Bartres-Faz D, Rami L. Identifying earlier Alzheimer's disease: insights from the preclinical and prodromal phases. Neurodegener Dis 2012; 10: 158-160.
26. Janus C, Westaway D. Transgenic mouse models of Alzheimer's disease. Physiol Behav 2001; 73: 873-886.
27. Giménez-Llort L, Blazquez G, Canete T, et al. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid. Neurosci Biobehav Rev 2007; 31: 125-147.
28. Tan LL, Wong HB, Allen H. The impact of neuropsychiatric symptoms of dementia on distress in family and professional caregivers in Singapore. Int Psychogeriatr 2005; 17: 253-263.
29. Shin IS, Carter M, Masterman D, Fairbanks L, Cummings JL. Neuropsychiatric symptoms and quality of life in Alzheimer disease. Am J Geriatr Psychiatry 2005; 13: 469-474.
30. Hope T, Keene J, Gedling K, Fairburn CG, Jacoby R. Predictors of institutionalization for people with dementia living at home with a career. Int J Geriatr Psychiatry 1998; 13: 682-690.
31. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Geor-gotas A. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987; 48: 9-15.
32. Lladó A, Sánchez-Valle R. Focusing on atypical symptoms for improved diagnosis of early-onset alzheimer's disease. Future Neurology 2011; 6: 575-578.
33. Giménez-Llort L, Blázquez G, Cañete T, et al. Modeling neuropsy-chiatric symptoms of Alzheimer's disease dementia in 3xTg-AD mice. In: Iqbal, k., Winblad, B., Avila, J., editors. Alzheimer's Disease: New Advances. Englewood N J USA Medimond 2006; pp: 13-16.
34. Sperling RA, Dickerson BC, Pihlajamaki M, et al. Functional alterations in memory networks in early Alzheimer's disease. Neu-romolecular Med 2010; 12: 27-43.
35. Oddo S, Caccamo A, Shepherd JD, et al. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles: Intracellular A(3 and Synaptic Dysfunction. Neuron 2003; 39: 409-421.
36. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. In-traneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005; 45: 675-688.
37. España J, Giménez-Llort L, Valero J, et al. Intraneuronal β-Amyloid Accumulation in the Amygdala Enhances Fear and Anxiety in Alzheimer's Disease Transgenic Mice. Biol Psychiatry 2010; 67: 513-521.
38. Giménez-Llort L, Arranz L, Mate I, De La Fuente M. Gender-specific neuroimmunoendocrine aging in a triple-transgenic 3xTg-AD mouse model for Alzheimer's disease and its relation with longevity. Neuroimmunomodulation 2008; 15: 331-43.
39. Giménez-Llort L, Garcia Y, Buccieri K, et al. Gender-Specific Neuroimunoendocrine Response to Treadmill Exercise in 3xTg-AD Mice. Int J Alzheimers Dis 2010; 2010: 128354.
40. Giménez-Llort L, Ramirez-Boix P, García Y, LaFerla FM, Sanfeliu C. Modeling neuropsychiatric symptoms of Alzheimer's disease in 3xTgAD mice: Neophobia, anxiety and aggressiveness at advanced stages of the disease. Proceedings of the Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) 2010 July 10-15 Honolulu, HI, USA Alzheimer's & Dementia 2010; 6: S227.
41. García-Mesa Y, Lopez-Ramos JC, Gimenez-Llort L, Revilla S, Guerra R, Gruart A, et al. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. J Alzheimers Dis 2011; 24: 421-454.
42. García-Mesa Y, Giménez-Llort L, López LC, et al. Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse. Neurobiol Aging 2012; 33: 1124.e13-1124.e29.
43. Torres-Lista V, Giménez-Llort L. Impairment of nesting behavior in 3xTg-AD mice. Behav Brain Res 2013; 247: 153-157
44. Parrado Fernandez C, Torres-Lista V, Alvarez-Montón I, et al. Early Indicators Of Oxidative Stress And Onset Of BPSD-Like Symptoms In Prodromic Stages Of Alzheimer'S Disease In 3xTg-AD Mice. Proceedings of the 8th Fens Forum of Neuroscience; 2012 July 14-18; Barcelona, Spain. The European Journal of Neuroscience.
45. Torres-Lista V, De La Fuente M, Giménez-Llort L. Time-course of BPSD-like-behaviors and the organometrics of peripheral immune system in 3xTg-AD mice from prodromal to early-stages of Alzheimer's disease. Proceedings of the 11th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD); 2013; Florence, Italy.
46. Giménez-Llort L, Rivera-Hernández G, Marin-Argany M, Sánchez-Quesada JL, Villegas S. Early intervention in the 3xTg-AD mice with an amyloid P-antibody fragment ameliorates first hallmarks of Alzheimer disease. Landes Bioscience 2013; 5: 5, 1-13.
47. Sterniczuk R, Dyck RH, LaFerla FM, Antle MC. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 1. Circadian changes. Brain Res 2010; 1348: 139-148.
48. Sterniczuk R, Antle MC, Laferla FM, Dyck RH. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes. Brain Res 2010; 1348: 149-155.
49. McGeer EG, McGeer PL. The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol 1998; 33: 371-378.
50. Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 2005; 25: 8843-8853.
51. Janelsins MC, Mastrangelo MA, Oddo S, LaFerla FM, Federoff HJ, Bowers WJ. Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation 2005; 2: 23.
52. Borkan GA, Norris AH. Assessment of biological age using a profile of physical parameters. J Gerontol 1980; 35: 177-184.
53. Wayne SJ, Rhyne RL, Garry PJ, Goodwin JS. Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. J Gerontol 1990; 45: M45-M48.
54. Guayerbas N, Catalan M, Victor VM, Miquel J, De La Fuente M. Relation of behaviour and macrophage function to life span in a murine model of premature immunosenescence. Behav Brain Res 2002; 134: 41-48.
55. Guayerbas N, De La Fuente M. An impairment of phagocytic function is linked to a shorter life span in two strains of prematurely aging mice. Dev Comp Immunol 2003; 27: 339-350.
56. Arranz L, De Castro NM, Baeza I, Mate I, Viveros MP, De La Fuente M. Environmental enrichment improves age-related immune system impairment: long-term exposure since adulthood increases life span in mice. Rejuvenation Res 2010; 13: 415-428.
57. De La Fuente M, Giménez-Llort L. Models of aging of neuroimmu-nomodulation: strategies for its improvement. Neuroimmunomodu-lation 2010; 17: 213-216.
58. Mattson MP, Duan W, Lee J, Guo Z. Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms. Mech Ageing Dev 2001; 122: 757-758.
59. Guayerbas N, Puerto M, Ferrandez MD, De La Fuente M. A diet supplemented with thiolic anti-oxidants improves leucocyte function in two strains of prematurely ageing mice. Clin Exp Pharmacol Physiol 2002; 29: 1009-1014.
60. De La Fuente M, Hernanz A. The antioxidant N-acetylcysteine in vitro improves several functions of peritoneal leucocytes from old mice approaching their values to those of adult animals. J Appl Biomed 2011; 2: 79-90.
61. Giménez-Llort L. The snail and turtle effects: Reflections on health care management in geriatric medicine. Eur Geriatric Med 2010; 1: 372.
62. Warburton DE., Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. CMAJ 2006; 174: 801-809.
63. Fragala MS, Kraemer WJ, Denegar CR, Maresh CM, Mastro AM, Volek JS. Neuroendocrine-immune interactions and responses to exercise. Sports Med 2011; 41: 621-639.
64. Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 2002; 25: 295-301
65. Fernández-Teruel A, Giménez-Llort L, Escorihuela RM, et al. Early-life handling stimulation and environmental enrichment: are some of their effects mediated by similar neural mechanisms? Pharmacol Biochem Behav 2002; 73: 233-245.
66. Khaw KT, Wareham N, Bingham S, Welch A, Luben R, Day N. Combined impact of health behaviours and mortality in men and women: the EPIX-Norfolk prospective population study. PLoS Med. 5, e12.
67. Benaroya-Milshtein N, Hollander N, Apter A, et al. Environmental enrichment in mice decreases anxiety, attenuates stress responses and enhances natural killer cell activity. Eur J Neurosci 2004; 20: 1341-1347.
68. Zambrana C, Marco EM, Arranz L, de Castro NM, Viveros MP, De La Fuente M. Influence of aging and enriched environment on motor activity and emotional responses in mice. Ann N Y Acad Sci 2007; 1100: 543-552.
69. Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discove 2004; 3: 205-214.
70. De La Fuente M, Hernanz A, Vallejo MC. The immune system in the oxidative stress conditions of aging and hypertension: favorable effects of antioxidants and physical exercise. Antioxid Redox Signal 2005; 7: 1356-1366.
71. Kamphuis PJ, Scheltens P. Can nutrients prevent or delay onset of Alzheimer's disease? J Alzheimers Dis 2010; 20: 765-775.